The high-performance single-seater 777 hypercar is born in Monza
(Monza, Italy): – The 777 hypercar is a new Italian hypercar born of the excellent partnership with Andrea Levy, Dallara, and Gibson, built from technology used in motorsports and all informations and images are on www.777hypercar.com.
777 hypercar is built by 777 Motors, the car manufacturer based in the Autodromo Nazionale Monza and founded by Andrea Levy, an entrepreneur, car collector, racing driver, and president of MIMO Milano Monza Motorshow. The 777 hypercar project will be presented on November 22, limited to just 7 units, each of which will cost 7 million euros.
777 hypercar is at the top for performance thanks to an FIA-homologated carbon monocoque developed by Dallara, which generate an incredible downforce of 2,100 kg at a speed of 370 km/h, an extremely low weight of 900 kg, and a lateral acceleration from 3.5 to 4 g that keeps the car glued to the asphalt, giving an incredible estimate lap time of just 1 minute and 33 seconds in the Monza Circuit. The engine is a naturally aspirated V8, 4,500 cc of displacement, which develops 730 hp at 9,000 rpm, powered by synthetic fuels.
Along with the 777 hypercar, owners will also receive custom attire and machinery, tailored to their liking. An advanced machine is created for ad hoc to reinforce the neck area.
Data sheet 777 hypercar engineered by Dallara:
Headquarters: Autodromo Nazionale di Monza, the Temple of Speed
Chassis: FIA-homologated carbon monocoque
Engine: 8 V-cylinders
Displacement: 4,500 cc
Power: 730 hp at 9,000 rpm
Top speed: 370 km / h.
Weight: 900 kg
Lateral acceleration: 3.5 / 4.0 g.
Downforce: 2,100 kg at 370 km / h
Monza lap time: 1m33s
Limited edition of seven units
Price: 7 million euros
Delivery: from 2025
Contacts
Barbara SantisePress Contact777 hypercar
barbara.santise@777hypercar.comwww.777hypercar.comImages
About news aktuell GmbH
news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
Biomay Obtains FDA Approval for Manufacturing of Cas9 Nuclease at Headquarters Site29.4.2025 14:00:00 CEST | Press release
The company announced its successful approval by the U.S. Food and Drug Administration (FDA) for the manufacturing, testing and release of recombinant Cas9 nuclease from its headquarters site. Cas9 is an essential component of CRISPR-based gene editing therapies, including CASGEVY® (exagamglogene autotemcel) developed and launched by Vertex Pharmaceuticals.
Bertelsmann Stiftung: Growth and innovation as cornerstones of a strong de-mocracy and a digitally sovereign Europe29.4.2025 12:00:00 CEST | Press release
Germany should be restored to a growth path and should give new impulse to innovation, along with its European partners. Because prosperity is a significant guarantor of a stable democracy. Digital sovereignty is the anchor of a strong Europe. Germany can once again be a country of pioneering innovation and a pacesetter for the continent. For this, comprehensive modernization of the state is indispensable. The Bertelsmann Stiftung presented its proposals at the annual press conference.
Acousia Therapeutics Reaches 50% Patient Enrollment Milestone in Phase 2 PROHEAR Study29.4.2025 09:00:00 CEST | Press release
Tübingen, Germany, April 29, 2025 Acousia Therapeutics GmbH announced that it has successfully enrolled 50% of patients in its ongoing Phase 2 clinical trial, the PROHEAR Study, evaluating ACOU085 (INN: bimokalner) for the prevention of cisplatin-induced hearing loss in patients with testicular cancer undergoing chemotherapy.
Australia’s next government must mend structural cracks appearing in its political, economic and social foundation, report finds28.4.2025 08:33:05 CEST | Press release
Australia boasts some of the world’s most sophisticated political institutions and one of its wealthiest economies. But this veneer of success masks deeper structural issues — and a “ticking time bomb” of overreliance on extractive industries must be addressed under Australia’s next government, a new report recommends.
EOPA Best Business Product of the Year 2025 - DYMO LetraTag 200B (Source:OPI)25.4.2025 08:00:04 CEST | Press release
DYMO® LETRATAG 200B WINS PRESTIGIOUS “BUSINESS PRODUCT OF THE YEAR” AWARD - REINFORCING RISE OF SMART ORGANIZATION
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom